FDA NDC Directory · JSON-LD · Markdown

Methotrexate

NDC 61703-161 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerHospira, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA011719
Dosage form / routeINJECTION, SOLUTION · INTRAMUSCULAR INTRATHECAL INTRAVENOUS SUBCUTANEOUS
Active ingredientsMETHOTREXATE SODIUM (25 mg/mL)
Marketing started20241104
Package count1

External sources

Source: openFDA. Public-domain (CC0).